Section Arrow
KRYS.NASDAQ
- Krystal Biotech
Quotes are at least 15-min delayed:2024/10/31 18:56 EDT
Last
 172.47
-3.06 (-1.74%)
Day High 
175.92 
Prev. Close
175.53 
1-M High
185.21 
Volume 
190.87K 
Bid
172.16
Ask
172.65
Day Low
170.09 
Open
174.99 
1-M Low
169 
Market Cap 
5.04B 
Currency USD 
P/E 44.44 
%Yield -- 
10-SMA 176.21 
20-SMA 176.23 
50-SMA 184.01 
52-W High 219.34 
52-W Low 93.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.95/6.94
Enterprise Value
5.05B
Balance Sheet
Book Value Per Share
29.20
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
50.70M
Operating Revenue Per Share
0.30
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 18:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.